Dabigatran etexilate for the prevention of stroke and systemic embolism in atrial fibrillation: NICE guidance

被引：18

作者：

Ahmad, Yousif ^{[1
]}

Lip, Gregory Y. H. ^{[1
]}

机构：

[1] Univ Birmingham, City Hosp, Ctr Cardiovasc Dis, Birmingham, W Midlands, England

来源：

HEART | 2012年 / 98卷 / 19期

关键词：

RISK STRATIFICATION; ORAL ANTICOAGULANTS; BLEEDING RISK; WARFARIN; THROMBOSIS; DOCUMENT; SCHEMES; TRIAL;

D O I：

10.1136/heartjnl-2012-302101

中图分类号：

R5 [内科学];

学科分类号：

100201 [内科学];

摘要：

[No abstract available]

引用

收藏

页码：1404 / 1406

页数：3

相关论文

共 21 条

[1]

New oral anticoagulant drugs in cardiovascular disease [J].

Ahrens, Ingo ;

Lip, Gregory Y. H. ;

Peter, Karlheinz .

THROMBOSIS AND HAEMOSTASIS, 2010, 104 (01) :49-60

[2]

[Anonymous], DAB ET PREV STROK SY

[3]

Anticoagulant Options - Why the FDA Approved a Higher but Not a Lower Dose of Dabigatran [J].

Beasley, B. Nhi ;

Unger, Ellis F. ;

Temple, Robert .

NEW ENGLAND JOURNAL OF MEDICINE, 2011, 364 (19) :1788-1790

[4]

Dabigatran versus Warfarin in Patients with Atrial Fibrillation. [J].

Connolly, Stuart J. ;

Ezekowitz, Michael D. ;

Yusuf, Salim ;

Eikelboom, John ;

Oldgren, Jonas ;

Parekh, Amit ;

Pogue, Janice ;

Reilly, Paul A. ;

Themeles, Ellison ;

Varrone, Jeanne ;

Wang, Susan ;

Alings, Marco ;

Xavier, Denis ;

Zhu, Jun ;

Diaz, Rafael ;

Lewis, Basil S. ;

Darius, Harald ;

Diener, Hans-Christoph ;

Joyner, Campbell D. ;

Wallentin, Lars .

NEW ENGLAND JOURNAL OF MEDICINE, 2009, 361 (12) :1139-1151

[5]

Risks of stroke and mortality associated with suboptimal anticoagulation in atrial fibrillation patients [J].

Gallagher, Arlene M. ;

Setakis, Efrosini ;

Plumb, Jonathan M. ;

Clemens, Andreas ;

van Staa, Tjeerd-Pieter .

THROMBOSIS AND HAEMOSTASIS, 2011, 106 (05) :968-977

[6]

Antithrombotic treatment and the risk of death and stroke in patients with atrial fibrillation and a CHADS2 score=1 [J].

Gorin, Laurent ;

Fauchier, Laurent ;

Nonin, Emilie ;

de Labriolle, Axel ;

Haguenoer, Ken ;

Cosnay, Pierre ;

Babuty, Dominique ;

Charbonnier, Bernard .

THROMBOSIS AND HAEMOSTASIS, 2010, 103 (04) :833-840

[7]

Myocardial Ischemic Events in Patients With Atrial Fibrillation Treated With Dabigatran or Warfarin in the RE-LY (Randomized Evaluation of Long-Term Anticoagulation Therapy) Trial [J].

Hohnloser, Stefan H. ;

Oldgren, Jonas ;

Yang, Sean ;

Wallentin, Lars ;

Ezekowitz, Michael ;

Reilly, Paul ;

Eikelboom, John ;

Brueckmann, Martina ;

Yusuf, Salim ;

Connolly, Stuart J. .

CIRCULATION, 2012, 125 (05) :669-676

[8]

Dabigatran etexilate for stroke prevention in patients with atrial fibrillation: Resolving uncertainties in routine practice [J].

Huisman, Menno V. ;

Lip, Gregory Y. H. ;

Diener, Hans-Christoph ;

Brueckmann, Martina ;

van Ryn, Joanne ;

Clemens, Andreas .

THROMBOSIS AND HAEMOSTASIS, 2012, 107 (05) :838-847

[9]

The CHADS2 score for stroke risk stratification in atrial fibrillation - friend or foe? [J].

Karthikeyan, Ganesan ;

Eikelboom, John W. .

THROMBOSIS AND HAEMOSTASIS, 2010, 104 (01) :45-48

[10]

Validation of the CHADS2 clinical prediction rule to predict ischaemic stroke A systematic review and meta-analysis [J].

Keogh, Claire ;

Wallace, Emma ;

Dillon, Ciara ;

Dimitrov, Borislav D. ;

Fahey, Tom .

THROMBOSIS AND HAEMOSTASIS, 2011, 106 (03) :528-538